Financhill
Sell
41

PCVX Quote, Financials, Valuation and Earnings

Last price:
$91.16
Seasonality move :
4.02%
Day range:
$90.79 - $93.77
52-week range:
$58.10 - $121.06
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
3.36x
Volume:
1.2M
Avg. volume:
1.2M
1-year change:
43.26%
Market cap:
$11.5B
Revenue:
--
EPS (TTM):
-$4.60

Analysts' Opinion

  • Consensus Rating
    Vaxcyte has received a consensus rating of Buy. The company's average rating is a Buy based on 8 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $149.89, Vaxcyte has an estimated upside of 62.69% from its current price of $92.13.
  • Price Target Downside
    According to analysts, the lowest downside price target is $135.00 representing 100% downside risk from its current price of $92.13.

Fair Value

  • According to the consensus of 8 analysts, Vaxcyte has 62.69% upside to fair value with a price target of $149.89 per share.

PCVX vs. S&P 500

  • Over the past 5 trading days, Vaxcyte has overperformed the S&P 500 by 5.37% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Vaxcyte does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Vaxcyte has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Vaxcyte reported revenues of --.

Earnings Growth

  • Vaxcyte has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Vaxcyte reported earnings per share of -$0.83.
Enterprise value:
9.3B
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-15.10x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Income Statement
Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
Operating Income -$173.6M -$329.3M -$528.2M -$111.4M -$139.6M
EBITDA -$166M -$335.1M -$528.2M -$108.9M -$135.1M
Diluted EPS -$2.95 -$3.33 -$4.60 -$0.91 -$0.83
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Balance Sheet
Current Assets $400.8M $302.9M $369.8M $1.3B $2.2B
Total Assets $403.8M $354.1M $412.1M $1.5B $3.6B
Current Liabilities $39.6M $47.5M $39.3M $85.6M $123.8M
Total Liabilities $39.7M $48.1M $52.8M $93.3M $142.1M
Total Equity $364.1M $306M $359.3M $1.4B $3.4B
Total Debt -- -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Cash Flow Statement
Cash Flow Operations -$156.5M -$233.2M -$470M -$57.5M -$60.7M
Cash From Investing $110.6M -$795.3M -$1.5B $22.3M -$917M
Cash From Financing $213.7M $1.3B $2.4B $48.6M $1.5B
Free Cash Flow -$162.6M -$245.2M -$616.2M -$64.9M -$98.8M
PCVX
Sector
Market Cap
$11.5B
$45.3M
Price % of 52-Week High
76.11%
47.7%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.79%
1-Year Price Total Return
43.26%
-33.16%
Beta (5-Year)
--
0.745
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $88.82
200-day SMA
Buy
Level $86.53
Bollinger Bands (100)
Sell
Level 87.24 - 112.36
Chaikin Money Flow
Buy
Level 2.1M
20-day SMA
Buy
Level $85.38
Relative Strength Index (RSI14)
Buy
Level 58.36
ADX Line
Buy
Level 20.39
Williams %R
Sell
Level -10.0923
50-day SMA
Buy
Level $87.92
MACD (12, 26)
Buy
Level 0.54
25-day Aroon Oscillator
Buy
Level 36
On Balance Volume
Neutral
Level 75M

Financial Scores

--
Altman Z-Score (Annual)
Level (--)
--
CA Score (Annual)
Level (--)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (10)
--
Ohlson Score
Level (--)
--
Piotroski F Score (Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.

Stock Forecast FAQ

In the current month, PCVX has received 8 Buy ratings 0 Hold ratings, and 0 Sell ratings. The PCVX average analyst price target in the past 3 months is $149.89.

  • Where Will Vaxcyte Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Vaxcyte share price will rise to $149.89 per share over the next 12 months.

  • What Do Analysts Say About Vaxcyte?

    Analysts are divided on their view about Vaxcyte share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Vaxcyte is a Sell and believe this share price will drop from its current level to $135.00.

  • What Is Vaxcyte's Price Target?

    The price target for Vaxcyte over the next 1-year time period is forecast to be $149.89 according to 8 Wall Street analysts, 8 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is PCVX A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Vaxcyte is a Buy. 8 of 8 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of PCVX?

    You can purchase shares of Vaxcyte via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Vaxcyte shares.

  • What Is The Vaxcyte Share Price Today?

    Vaxcyte was last trading at $91.16 per share. This represents the most recent stock quote for Vaxcyte. Yesterday, Vaxcyte closed at $92.13 per share.

  • How To Buy Vaxcyte Stock Online?

    In order to purchase Vaxcyte stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

1 Space Stock Up Over 150%, More To Go?
1 Space Stock Up Over 150%, More To Go?

Planet Labs combines satellite imaging and data analytics technologies to…

How High Will Rubrik Stock Go?
How High Will Rubrik Stock Go?

Shares of cybersecurity company Rubrik (NYSE:RBRK) have been on a…

Stanley Druckenmiller’s Portfolio Playbook: Lessons from a Billionaire Investor
Stanley Druckenmiller’s Portfolio Playbook: Lessons from a Billionaire Investor

Stanley Druckenmiller may be best known for his role with…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 39x

Buy
60
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 38x

Sell
44
Is NVDA Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 108x

Alerts

Buy
72
MNPR alert for Jan 29

Monopar Therapeutics [MNPR] is down 16.19% over the past day.

Buy
84
PSIX alert for Jan 29

Power Solutions International [PSIX] is up 5.88% over the past day.

Buy
75
HZO alert for Jan 29

MarineMax [HZO] is down 2.67% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock